Search clinical trials for: Corfluvec component 2 low dose

Total 2910 results

Glenmark Pharmaceuticals Ltd. India
Glenmark Pharmaceuticals S.A.

Withdrawn

A Clinical Trial to Study the Effects of GRC 17536 in Patients With Painful Diabetic Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients)

Painful Diabetic Neuropathy

Germany, United Kingdom
Kyung Hee University Hospital at Gangdong
SMG-SNU Boramae Medical Center; Chungbuk National University Hospital; Korea...

Recruiting

The Clinical Trial of Low Dose Irradiation for Alzheimer's Disease (LDRT-AD-02)

Alzheimer Disease

Korea, Republic of
Turku University Hospital

Suspended

The Optimization of a Low-dose CT Protocol in Patients With Suspected Uncomplicated Acute Appendicitis and BMI >30 (OPTICAP>30)

Intra-abdominal Infection | Acute Disease | Appendicitis | Gastrointestinal Disease | Other and Unspecified Acute Appendicitis

Finland
Seoul National University Bundang Hospital

Completed

Optimum Hand Position During Cardiopulmonary Resuscitation

Cardiopulmonary Resuscitation | Hand Position
Erasme University Hospital

Completed

CT Indexes of Emphysema and Airways in Healthy Volunteers: Normal Values; Relations With Gender, Height and Weight

Healthy

Belgium
Frontera Therapeutics

Recruiting

Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy

Biallelic RPE65 Mutation-associated Retinal Dystrophy

China
Boehringer Ingelheim

Completed

BI 6727 (Volasertib) Monotherapy Phase I Trial in Japanese Patients With Advanced Solid Tumours

Neoplasms

Japan
Pharnext SA

Completed

Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A

Charcot-Marie-Tooth Disease | Hereditary Neuropathy With Liability to Pressure Palsies | Genetic Disorders

France
GlaxoSmithKline

Completed

GSK618334 Repeat Dose Study

Substance Dependence

United Kingdom
Mymetics Corporation
Institut Cochin; San Raffaele University Hospital, Italy; Kinesis Pharma B.V.; ... and other collaborators

Completed

Investigation of the Safety of an HIV-1 Vaccine Given Intra-muscularly and Intra-nasally to Healthy Female Subjects

HIV-1

Belgium
University Health Network, Toronto

Active, not recruiting

Low-Dose CT - Stage I Testicular Cancer

Testicular Cancer

Canada
Sheba Medical Center

Completed

Ultra-Low Dose CT Denoising for Lung Nodule Detection

Pulmonary Nodule, Multiple

Israel
British Columbia Cancer Agency

Unknown

Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy (FTPC)

Prostate Cancer

Canada
ANRS, Emerging Infectious Diseases

Completed

Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study (EP48 HIV CHEST)

Lung Cancer | Hiv Infection

France
Themis Bioscience GmbH

Completed

Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005)

Chikungunya Virus Infection

United Kingdom
Sheba Medical Center
Rambam Health Care Campus; AstraZeneca; Tel-Aviv Sourasky Medical Center

Recruiting

Concomitant Radiotherapy, Tremelimumab & Durvalumab for Advanced NSCLC Patients Progressing on First-line Immunotherapy (CORAL-Lung)

Metastatic or Locally Advanced NSCLC

Israel
Kangpu Biopharmaceuticals, Ltd.

Completed

Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE (Lupus)

SLE; Drug

United States
Mitsubishi Tanabe Pharma Corporation

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms

Vasomotor Symptoms

Germany
Merck Sharp & Dohme LLC

Completed

Study of a Dengue Vaccine (V180) in Healthy Adults (V180-001)

Dengue
Medical University of Warsaw

Recruiting

Induction of Sustained Unresponsiveness to Peanuts Using High- and Low-dose Peanut Oral Immunotherapy

Peanut Allergy

Poland
Ohio State University Comprehensive Cancer Center
Varian Medical Systems

Active, not recruiting

Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia (PREVENT)

Pneumonia | Covid-19 | Sars-CoV2

United States, Colombia
Seoul National University Hospital

Active, not recruiting

Renal Protocol Protection in CKD Patients

HCC | CKD

Korea, Republic of
Beijing Konruns Pharmaceutical Co., Ltd.

Completed

The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

Chronic Pelvic Pain

China
National Institute of Allergy and Infectious Diseases...

Completed

Pharmacokinetics of Two Intravaginal Rings (IVRs) Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048

HIV Infections

United States
Xuzhou Central Hospital

Completed

Low-dose Protocol for Computed Tomography-guided Lung Biopsy

Lung Cancer, Adenocarcinoma | Lung Inflammatory Pseudotumor

China
Aronora, Inc.

Completed

Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis

Thrombosis | End Stage Renal Disease

United States
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Completed

Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells (CLIPA)

Leukemia | Leukemia, B-Cell, Chronic

United States
Anhui Provincial Hospital

Recruiting

Hypofraction Radiotherapy for Limited-Stage Small Cell Lung Cancer

Safety Issues | Efficacy, Self

China
Receptor Life Sciences

Withdrawn

Safety, Tolerability, and Efficacy of RLS103 in Subjects With Acute Anxiety Within Social Anxiety Disorder (SAD)

Social Anxiety Disorder

United States
Medical University of Warsaw

Enrolling by invitation

Induction of Sustained Unresponsiveness to Sesame Using High- and Low-dose Sesame Oral Immunotherapy

Food Allergy

Poland
Janssen Research & Development, LLC

Completed

A Study of Seltorexant (JNJ-42847922) After Single-Dose Administration in Healthy Participants

Healthy

United States
Hospital St. Joseph, Marseille, France

Recruiting

Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers

Smoking

France
Lawson Health Research Institute

Recruiting

Potency pReservation In Prostate cAncer Patients Treated With UltraSound-guided Low-dose Rate Brachytherapy (PRIAPUS)

Prostate Cancer

Canada
Mayo Clinic

Active, not recruiting

Ultra-low-dose Chest CT for HHT

Hereditary Hemorrhagic Telangiectasia

United States
Helsinki University Central Hospital
Finnish Cancer Society

Completed

Low-dose Computer Tomography in Follow-up of Soft Tissue Sarcomas

Sarcoma,Soft Tissue

Finland
Turku University Hospital

Completed

The Optimization of a Low-dose Computed Tomography Protocol in Patients With Suspected Uncomplicated Acute Appendicitis (OPTICAP)

Gastrointestinal Diseases | Intra-abdominal Infection | Acute Disease | Appendicitis | Other and Unspecified Acute Appendicitis

Finland
Far Eastern Memorial Hospital

Completed

L1 M1 of LDCT for Low Muscle Mass Measurement

Sarcopenia

Taiwan
RWTH Aachen University
Heinrich-Heine University, Duesseldorf

Withdrawn

Relevance of Flavanols for Cardiovascular Function in End-Stage Renal Disease (ESRD)

End Stage Renal Disease

Germany
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Recruiting

Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLE

Lupus Erythematosus, Systemic

China
Visterra, Inc.

Completed

Safety and Efficacy Study of VIS649 for IgA Nephropathy

Immunoglobulin A Nephropathy | Glomerular Disease | IgAN

United States, Australia, Canada, Hong Kong, India, Japan, Korea, Republic of, Malaysia, Philippines, Singapore, Spain, Sri Lanka, Taiwan, Thailand, United Kingdom
Jiangsu Kanion Pharmaceutical Co., Ltd

Completed

Effect of KYG0395 on Primary Dysmenorrhea

Primary Dysmenorrhea

United States
Boehringer Ingelheim
Eli Lilly and Company

Completed

Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States, France, Israel, Mexico, South Africa
Shanghai Zerun Biotechnology Co.,Ltd
Walvax Biotechnology Co., Ltd.

Active, not recruiting

Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

COVID-19

China
Boehringer Ingelheim

Completed

Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, Compared to Metoprolol Succinate and Placebo in Healthy Volunteers

Healthy
Shanghai Zerun Biotechnology Co.,Ltd
Walvax Biotechnology Co., Ltd.

Active, not recruiting

Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

COVID-19

China
Mario Negri Institute for Pharmacological Research
Ministry of Health, Italy; Azienda Ospedaliera San Gerardo di Monza

Active, not recruiting

Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW) (STANDLOW)

Epilepsies, Partial

Italy
Genocea Biosciences, Inc.

Completed

Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine

Streptococcus Pneumoniae

United States
KBio Inc

Completed

Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults

Influenza

United States
Alkermes, Inc.

Completed

A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia

Schizophrenia

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy

Painful Diabetic Peripheral Neuropathy

Germany, Hungary, Poland

Search clinical trials for: Corfluvec component 2 low dose

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations